STOCK TITAN

TERRASCENT CORP - $TSNDF STOCK NEWS

Welcome to our dedicated page for TERRASCENT news (Ticker: $TSNDF), a resource for investors and traders seeking the latest updates and insights on TERRASCENT stock.

Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect TERRASCENT's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.

Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of TERRASCENT's position in the market.

News
Rhea-AI Summary
TerrAscend Corp. launches Legend mini pre-roll packs in New Jersey, offering consumers quality cannabis flower at everyday prices. The packs will be available exclusively at Apothecarium dispensaries in New Jersey starting April 26, expanding to the rest of the state on April 29. Each pack contains eight .375g pre-rolls with unique blends of two to three strains, catering to different preferences. TerrAscend aims to meet consumer demand for smaller, affordable, and convenient cannabis products, reinforcing its commitment to innovation in the New Jersey market.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.96%
Tags
none
-
Rhea-AI Summary
TerrAscend Corp. to host conference call to discuss first quarter 2024 financial results on May 9, 2024. Investors can access the webcast or dial-in for details.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-8.7%
Tags
conferences earnings
-
Rhea-AI Summary
TerrAscend Corp. reports a record Net Revenue of $317.3 million in 2023, marking a 28.0% increase year-over-year. The company also achieved a Gross Profit margin of 50.3%, showing a 930 basis-point improvement. Adjusted EBITDA from continuing operations reached $68.8 million, up by 77.1% year-over-year. TerrAscend delivered its first full year of positive Cash Flow and Free Cash Flow.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
6.21%
Tags
Rhea-AI Summary
TerrAscend Corp. to discuss Q4 and full-year 2023 results in conference call on March 14, 2024.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.78%
Tags
conferences earnings
-
Rhea-AI Summary
TerrAscend Corp. celebrates Governor Shapiro's endorsement of Pennsylvania's adult-use cannabis program, proposing legalization effective July 1st, 2024, and full adult-use sales commencing January 1, 2025. This move is expected to expand TerrAscend's offerings to adult-use consumers, making Pennsylvania its largest market. TerrAscend currently operates six dispensaries and its largest cultivation and production facility in the state.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.04%
Tags
none
-
Rhea-AI Summary
TerrAscend Corp. expands its Valhalla product lineup to include one of the first 100mg edibles in Pennsylvania, aiming to meet rising patient expectations. The high-potency troches will be available at all Apothecarium locations and additional dispensaries throughout the state, offering convenience and innovation to patients.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
3.63%
Tags
none
Rhea-AI Summary
TerrAscend Corp. (
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-3.54%
Tags
conferences
-
Rhea-AI Summary
TerrAscend Corp. (TSX: TSND) (OTCQX: TSNDF) reported a 34.7% year-over-year and 23.7% sequential increase in net revenue to $89.2 million for Q3 2023. Gross profit margin improved to 53.6%, and adjusted EBITDA from continuing operations increased by 89% sequentially to $24.2 million. The company also raised its 2023 guidance for net revenue and adjusted EBITDA to $320 million and $73 million, respectively, implying 29% and 87% year-over-year growth. TerrAscend cited industry-leading revenue growth, gross margin expansion, and strong cash flow as key drivers of its performance.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
7.5%
Tags
-
Rhea-AI Summary
TerrAscend Corp. to host conference call to discuss third quarter 2023 financial results
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-4.47%
Tags
conferences earnings
Rhea-AI Summary
TerrAscend Corp. to participate in Jefferies Cannabis Summit
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.49%
Tags
conferences
TERRASCENT CORP

OTC:TSNDF

TSNDF Rankings

TSNDF Stock Data

639.18M
184.53M
7.15%
12.08%
Medicinal and Botanical Manufacturing
Manufacturing
Link
United States of America
Mississauga